603259 藥明康德
按盤價 
52.870 -1.530 (-2.813%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 27,702,002 | -6.23% | 40,340,807 | 39,354,778 | 22,902,385 | 16,535,431 | |
| 減：營業總成本 | 19,967,164 | -2.08% | 28,708,591 | 29,800,811 | 18,574,516 | 13,928,304 | |
| 其中:營業成本 | 16,440,256 | -5.20% | 23,728,800 | 24,677,217 | 14,592,256 | 10,253,276 | |
| 財務費用 | (61,970) | -90.52% | (338,119) | (247,968) | 84,082 | 519,804 | |
| 資產減值損失 | (20,104) | -67.30% | (156,509) | (175,951) | (33,056) | (62,642) | |
| 公允價值變動收益 | 217,647 | 111.97% | (37,809) | 770,079 | (93,387) | 52,271 | |
| 投資收益 | (164,810) | -135.56% | 233,849 | 187,949 | 1,356,269 | 606,231 | |
| 其中：對聯營企業和合營企業的投資收益 | 198,950 | -485.69% | (67,560) | (46,271) | (117,290) | (90,752) | |
| 營業利潤 | 7,890,869 | -19.54% | 11,872,286 | 10,652,249 | 6,037,725 | 3,389,485 | |
| 利潤總額 | 7,854,296 | -19.71% | 11,831,991 | 10,618,476 | 6,015,609 | 3,369,376 | |
| 減：所得稅費用 | 1,252,685 | -23.30% | 2,131,731 | 1,715,866 | 879,662 | 383,126 | |
| 淨利潤 | 6,601,612 | -18.99% | 9,700,260 | 8,902,611 | 5,135,947 | 2,986,250 | |
| 減：非控股權益 | 68,677 | -4.93% | 93,511 | 88,898 | 38,792 | 26,015 | |
| 股東淨利潤 | 6,532,935 | -19.11% | 9,606,749 | 8,813,713 | 5,097,155 | 2,960,235 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 2.250 | -18.18% | 3.270 | 3.010 | 1.750 | 1.060 | |
| 每股派息 (元) * | -- | -- | 0.990 | 0.893 | 0.517 | 0.363 | |
| 每股淨資產 (元) * | 18.947 | 9.04% | 18.570 | 15.737 | 13.020 | 13.308 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 15/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
